Target intelligence / Profile preview

Damage-associated molecular pattern and self-antigen (DAMP)

Target
DAMP
Molecular classification
Other
01

Overview

Damage-associated molecular patterns (DAMPs) and self-antigens are endogenous molecules that serve as signals of cellular stress, damage, or non-programmed cell death, triggering innate and adaptive immune responses (Roh & Sohn, 2018). DAMPs, such as high mobility group box 1 (HMGB1), S100 proteins, and heat shock proteins, are released into the extracellular space where they interact with pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) and the receptor for advanced glycation end-products (RAGE) (Gong et al., 2020). This interaction initiates sterile inflammation, which is crucial for tissue repair but can lead to chronic inflammatory diseases, sepsis, and cancer when dysregulated (Zindel & Kubes, 2020). Self-antigens are typically normal cellular components that become targets of the adaptive immune system in autoimmune disorders, such as myelin basic protein in multiple sclerosis or insulin in type 1 diabetes (Janeway et al., 2001). Therapeutic interventions targeting this category include monoclonal antibodies designed to neutralize specific DAMPs or small molecules that block their receptors to dampen pathological inflammation (Venereau et al., 2015). However, because many DAMPs have essential intracellular functions, therapeutic targeting requires precision to avoid interfering with normal physiological processes and wound healing (Harris et al., 2012).

Other names
AlarminEndogenous danger signalAutoantigenCell-death-associated molecular patternEndogenous ligand
02

Mechanism of action

Neutralization of endogenous ligands or blockade of pattern recognition receptors (PRRs) to inhibit downstream inflammatory signaling pathways (Venereau et al., 2015).

03

Biological functions

Immune responseInflammationCell deathSignal transductionWound healing
04

Disease associations

InflammationAutoimmune diseaseCancerNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

ImmunosuppressionImpaired wound healingOff-target effects due to physiological roles of endogenous moleculesSystemic toxicity
06

Interacting drugs

Paquinimod

6 more in the full profile.

07

Biomarkers

High mobility group box 1 (HMGB1) levelS100 protein levelCell-free DNA (cfDNA)Heat shock protein (HSP) level

Beyond the preview

Go deeper on Damage-associated molecular pattern and self-antigen (DAMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damage-associated molecular pattern and self-antigen (DAMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call